PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
J ECT. Author manuscript; available in PMC 2012 September 1.
Published in final edited form as:
PMCID: PMC3162076
NIHMSID: NIHMS252805

A Systematic Review of the Combined Use of Electroconvulsive Therapy and Psychotherapy for Depression

Abstract

Objective

Electroconvulsive therapy (ECT) is one of the most effective treatments for severe Major Depressive Disorder (MDD). However, after acute phase treatment and initial remission, relapse rates are significant. Strategies to prolong remission include continuation phase ECT, pharmacotherapy, psychotherapy, or their combinations. This systematic review synthesizes extant data regarding the combined use of psychotherapy with ECT for the treatment of patients with severe MDD and offers the hypothesis that augmenting ECT with depression-specific psychotherapy represents a promising strategy for future investigation.

Methods

The authors performed two independent searches in PsychInfo (1806 – 2009) and MEDLINE (1948 – 2009) using combinations of the following search terms: Electroconvulsive Therapy (including ECT, ECT therapy, electroshock therapy, EST, shock therapy) and Psychotherapy (including cognitive behavioral, interpersonal, group, psychodynamic, psychoanalytic, individual, eclectic, and supportive). We included in this review a total of six articles (English language) that mentioned ECT and psychotherapy in the abstract, and provided a case report, series, or clinical trial. We examined the articles for data related to ECT and psychotherapy treatment characteristics, cohort characteristics, and therapeutic outcome.

Results

Although research over the past seven decades documenting the combined use of ECT and psychotherapy is limited, the available evidence suggests that testing this combination has promise and may confer additional, positive functional outcomes.

Conclusions

Significant methodological variability in ECT and psychotherapy procedures, heterogeneous patient cohorts, and inconsistent outcome measures prevent strong conclusions; however, existing research supports the need for future investigations of combined ECT and psychotherapy in well-designed, controlled clinical studies. Depression-specific psychotherapy approaches may need special adaptations in view of the cognitive effects following ECT.

Keywords: Electroconvulsive therapy, Psychotherapy, Cognitive Behavior Therapy, Interpersonal Psychotherapy, Major Depressive Disorder

Introduction

Electroconvulsive therapy (ECT) is one of the most effective treatments for severe Major Depressive Disorder (MDD), carrying benefits of relatively high response and initial remission rates 1 in an efficient time frame (e.g., approximately three – four weeks) compared to other antidepressant treatments (e.g., six or more weeks) [1-5]. Despite the high efficacy of ECT, prolonged remission is uncertain, and threatened particularly by lack of continued care [6, 7]. To protect against relapse following an acute phase ECT, two primary strategies have been recommended: augmenting ECT with pharmacotherapy during the acute phase [8, 9], or continuing the treatment course beyond early response with only one of these treatments [10]. A new untested strategy entails combining antidepressant medication with ECT throughout the acute and continuation phases of treatment, with continuation ECT administration based upon individual symptom severity [11]. Yet, relative to the augmentation strategies common to pharmacotherapy, augmenting ECT with depression-specific psychotherapy has received limited attention [12].

There are two scientific rationales that support augmenting ECT with evidence-based psychotherapy. First, two contemporary psychotherapies, Cognitive Behavioral Therapy (CBT) [13] and Interpersonal Psychotherapy (IPT) [14, 15] (often referred to as depression-specific psychotherapy) have been found efficacious in both the acute and continuation phases of treatment for MDD and have been shown to prolong remission, and perhaps recovery [16-27]. In addition, there is a substantial body of research highlighting improved clinical and functional outcomes when evidenced-based psychotherapy is combined with pharmacotherapy in the long-term treatment and management of patients with chronic, treatment-resistant depression [28-30].

Second, neuroimaging suggests that ECT and depression-specific psychotherapy have distinct mechanisms of action that may result in specific treatment effects. Electroconvulsive therapy may decrease cerebral metabolic rate for glucose (rCMR) bilaterally in the superior frontal lobe (dorsolateral prefrontal cortex, medial prefrontal cortex), the parietal regions, posterior cingulate gyrus, and the medial temporal lobes [31]. On the other hand, studies suggest that there are early prefrontal changes with psychotherapy and differential responses throughout the course of therapy [32-35]. For example, both the hippocampus and mid-cingulate exhibit increased activity after psychotherapy while activity decreases in the orbital frontal and medial frontal cortices [32]. Such changes in the mood regulating areas of the brain potentiate thinking and behavior changes associated with psychotherapeutic techniques. It has been hypothesized that ECT may work from the “bottom-up,” whereas psychotherapy may work from the “top-down” [32, 34].

Considering the differential activation of these distinct brain regions, it seems reasonable to investigate the efficacy of augmenting ECT with depression-specific psychotherapy to improve the symptoms and functioning of patients suffering from severe MDD [36]. Although the literature reflects a significant amount of research concerning the augmentation of antidepressant medication with psychotherapy, it has been assumed by some that post-treatment cognitive impairment impeded the effectiveness of individual psychotherapy [37]. Documented side effects of ECT include memory deficits, specifically anterograde amnesia (up to one month) for newly learned information and retrograde amnesia (up to six months or longer) for autobiographical information [38]. These memory deficits seem to preclude psychotherapy, particularly if administered without awareness of the special needs of this population. However, given the advances in ECT and evidence-based psychotherapy, we hypothesize that with proper adaptation, depression-specific psychotherapy can be personalized as an augmentation intervention to meet the needs of severely depressed patients treated with ECT. The purposes of this paper are to provide a framework and rationale for this hypothesis, conduct a systematic review of available studies investigating previous combinations in the acute and continuation phase of treatment for MDD, and suggest starting points for developing this augmented or sequenced intervention for adults with severe depression.

Systematic Review Method

To accomplish the systematic literature review [39], we (authors SMM and ARB) performed independent searches in the PsychInfo (1806 – 2009) and Medline (1948 – 2009) databases with the following terms: Electroconvulsive Therapy (including ECT, ECT therapy, electroshock therapy, EST, shock therapy) and Psychotherapy (including cognitive behavioral, interpersonal, group, psychodynamic, psychoanalytic, individual, eclectic, supportive). To control for duplicate information and redundancy, the results of the two independent searches were imported into and managed with Endnote (version X2 for Mac, The Thomson Corp.). We included only those articles in this systematic review that mentioned ECT and psychotherapy (or one of the variants mentioned above) in the abstract, and provided a case report, series, or clinical trial. A total of six studies (English language literature) were included in this review. These studies were between the dates of 1946 – 2006, from the United States and United Kingdom; the methodologies varied from theoretical conceptualizations and case reports to randomized, controlled trials.

Combined Use of ECT and Psychotherapy

The earliest publication describing the incorporation of psychotherapy with EST2 reported upon 100 cases of “psychoneuroses” treated over a five-year period at St. James Hospital in Portsmouth, UK in 1946 [40]. The authors suggested that psychiatric symptoms were caused by faulty electrical patterns in the brain which, when altered by EST, resulted in an amnestic state that allowed for new simplified patterns to develop. “Simple psychotherapy” was given in the form of explanations and reassurance as the patient's memory returned, and occupational therapy was used to encourage the patient to take part in social activities. The course of treatment involved as many as four EST treatments a day, but no information is given in regard to the frequency or even the use of formal psychotherapy sessions with patients. Patients were considered “recovered” when symptom-free and stable enough for discharge, and considered “relieved” when much improved but when stability was in doubt. Within this nomenclature, 51% were classified as “recovered,” 46% as “relieved,” and 3% “not improved.”

More than ten years later, a group of American psychiatrists practicing at the Stony Lodge inpatient facility in New York published a preliminary report on 100 cases treated with “regressive electroshock treatment” or “REST” [41]. Although the majority of the cases were classified with some form of schizophrenia, two of the cases were diagnosed with “Manic Depression.” Considered a “drastic” treatment at the time (and today an unacceptable regimen by current psychiatric treatment standards), REST entailed multiple daily EST treatments continuing until the patient reached a state of infantile behavior characterized by amnesia, muteness, ataxia, and complete incontinence. At the termination of REST, the patient was then cared for as an infant, being slowly rehabilitated throughout the same developmental trajectory as a child (e.g., being carried, fed by bottle, spoon-fed, taught to sit up and walk, toilet trained) by Nursing Assistants with specialized training. Psychotherapy in the protocol consisted of two or three short visits daily over 10-14 days during which the patient began emerging from the regressed state. Psychotherapeutic techniques included answering questions, acting as the patient's lost memory, and serving as a reassuring, stable person upon whom a “helpless person” may depend. Patient outcome was classified along a continuum anchored by “unimproved” (no change) and “recovered” (disappearance of symptoms, ability to function, and with adequate insight). Of the two patients being treated for Manic Depression, only one was classified as “recovered” with the other identified as “improved.”

Regressive electroshock treatment is also reported upon in the case study of a patient treated at the Menninger Clinic [42]. Treatment was described as a total of 30 electroshock treatments over a period of ten consecutive days and, as memories returned, the patient was “re-educated” with psychotherapy three to four times a day by the treating psychiatrist. As the frequency of psychotherapy sessions was reduced, occupational therapy was introduced and, upon discharge from the hospital, outpatient treatment was transferred to a supportive psychotherapist.

Jaffe et al. [43] demonstrated the benefit of subconvulsive and convulsive electro-stimulation (EST) as an adjunctive treatment to individual psychotherapy in a case report of an adult female patient with multiple psychiatric diagnoses (e.g., depression, anxiety, anorexia). Upon not showing benefit from a non-specified psychotherapy alone, two courses of EST were adjunctively provided. The first course consisted of 12 subconvulsive treatments provided three times weekly, and the second course consisted of 14 convulsive treatments provided three times weekly. The patient was monitored by electroencephalography (EEG) during both EST courses. No change in EEG was observed with subconvulsive EST, but decreased slow wave activity was documented with convulsive EST. The authors suggested that the patient's clinical improvement was related to the physiologic changes in the EEG, and that EST can benefit psychotherapy.

Group psychotherapy, another approach to the combination of psychotherapy and EST, is described in the multidisciplinary treatment of depression in a hospital inpatient unit [44]. Goals of the group were focused upon the “reorganization and remolding of a patient's new growth” post-EST rather than upon augmenting treatment for the disorders themselves. Patients were encouraged to process their feelings about the shock treatment and its concomitant adverse effects (e.g., forgetfulness). The investigators reported favorable outcomes, including improvements in feelings of self-worth and self-awareness, reality-testing, and acquisition of positive coping mechanisms.

The most recent investigation of psychotherapy and ECT tested the potential benefits of CBT [37]. Although methodological concerns dictate cautious interpretation (e.g., N = 9, response established by clinician subjective report rather than by standardized instrument or masked independent evalutor, and lack of a control group), the authors concluded that CBT was of benefit to study participants. Specifically, patients who received 12 weeks of CBT after an index course of ECT for MDD either maintained their response to ECT or continued to show decreased depressive symptoms at six- and nine-month follow-ups as measured by the Beck Depression Inventory and the Clinical Global Impression scale. Methodological concerns aside, these preliminary data in a small sample suggest a hypothesis worthy of attention: augmenting ECT with effective depression-specific psychotherapy (e.g., CBT or IPT) will prove feasible, safe, and will promote remission for patients with severe depression.

Summary of Findings and Future Directions

Prior research investigating the combined use of ECT and psychotherapy has reported beneficial effects in the treatment of psychiatric illness, but all studies varied in methodology, lacked appropriate controls, and provided limited data, making replication or strong conclusions difficult. Most authors did not provide information on psychotherapy, ECT procedures, or outcome measures (i.e., type of stimulus wave form, electrode placement configuration, number of ECT treatments, type of psychotherapy, number of sessions, therapist qualifications, integrity of the psychotherapy, symptom or severity rating scales). Most important, the majority of the historical studies reviewed did not adhere to robust, controlled clinical science methods such as the inclusion of a comparative control group or control condition.

The established efficacy of depression-specific psychotherapy as monotherapy or augmentation in the treatment of chronic and/or severe MDD suggests that similar rigorous investigations of psychotherapy with ECT may fill an essential gap in clinical knowledge. Important covariates within the heterogeneous subtype of patients with MDD include patients with and without with melancholic features [45-47], MDD with atypical features [48, 49], MDD with psychotic features [50-53], recurrent MDD [54-56], and MDD with severe suicidal ideation [57-60].

A major challenge to combining these two therapeutic modalities is the cognitive sequelae of ECT which, if not taken into consideration, could potentially minimize the benefits of depression-specific psychotherapy. During the treatment course, disorientation (e.g., forgetting time of day, location) occurs and may last between 20 to 90 minutes post the ECT session. Anterograde amnesia has an onset during the first treatment and can persist for up to one month after the ECT course. Lastly, retrograde amnesia also has an onset during the first treatment and can persist for as long as six months after the ECT course [38, 61]. Although advances in ECT (see Table 2) have minimized the cognitive side effects, these are still problematic for patients (for a full review of the cognitive effects of ECT see Fraser et al. [62]).

Table 2
Advances in the Administration of Electroconvulsive Therapy to Reduce Cognitive Adverse Effects*

To mitigate the above challenge of temporarily impaired cognitive function, future investigations evaluating the efficacy and effectiveness of combination ECT and evidenced-based psychotherapy should ensure that both treatments are administered at optimum levels. Regarding ECT, parameters should be chosen that would result in the least adverse cognitive side effects. Specifically, ECT should be administered with ultra brief pulse waveform, dose titrated with the empirical titration method, electrode configuration should be right unilateral or bifrontal, and treatment should be systematically delivered until the patient achieves remission [63]. These parameters are essential to preserve cognitive functions [64-66]. For example, psychotherapeutic treatment could be provided on days when ECT is not administered to allow the patient to regain, to the fullest extent possible, adequate cognitive function. At the same time, key questions to ask are: What is the critical time point at which to introduce evidence-based psychotherapy, and what are the key psychotherapeutic components to include in such a strategy? Such studies have been done in pharmacotherapy research [67-69], but a paucity of information remains within psychotherapy for the depression and ECT literature. Moreover, with established evidence of the beneficial combination of evidence-based psychotherapy and medication [25], and ECT and medication [9], another question emerges: Should pharmacotherapy be introduced with the combination of evidenced-based psychotherapy and ECT?

Beginning depression-specific psychotherapy before ECT and continuing it afterward deserves study [70]. Key components of the psychotherapeutic intervention might consist first of an introduction to the basics of the given depression-specific psychotherapy, as well as MDD and ECT. Additional emphasis before ECT could be placed upon teaching strategies for cognitive remediation the patient could use when learning new concepts (in spite of any impaired memory functions). These key components need to be interwoven and repeated to produce a depression-specific psychotherapy tailored to patients with severe depression who also have cognitive adverse effects secondary to ECT.

Just as CBT and IPT have been adapted according to unique needs of specific populations, these standard structured approaches require modifications tailored to ECT patients. For example, in such “tailoring”, a heavy focus upon behavioral activation could be helpful [71]. Cognitive behavioral interventions like problem solving and cognitive restructuring can be applied to increase memory and cognitive flexibility (e.g., rehearsal to ensure that material discussed in sessions is maintained). Hypothesis testing and cognitive restructuring for thoughts such as, “How can I learn, when I can't remember?” would be crucial. The IPT model can be applied to feelings of grief or loss the patient may have regarding the severe depression, and the sequelae of both the illness and the treatment. Either approach encourages bringing in family members to increase the social support available to the patient, and helps significant others learn specific strategies to fulfill concrete needs of the patient during the recovery period.

Indeed, Hollon et al. [25] suggest that CBT and IPT are beneficial in patients with severe depression, may improve treatment response when combined with other antidepressant treatments (e.g., pharmacotherapy), and can have lasting therapeutic effects. Thus, there is evidence to suggest that CBT and IPT can be useful augmentation strategies for patients with severe depression. A next step would be to adapt those strategies for patients undergoing ECT.

Standard neurocognitive instruments such as the Mini Mental State Examination (MMSE) [72] or the Montreal Cognitive Assessment (MoCA) [73] may be useful to document the global cognitive function status of the patient to better assess suitability for psychotherapy or determine necessary adaptations during the therapy process. Though no specific neurocognitive instrument for use with patients undergoing ECT exists at this time, global cognitive instruments can help establish that the patient is oriented and is able to attend to verbal and visual information.

Additionally, prospective research may benefit from the American College of Neuropsychopharmacology (ACNP) Task Force [72] and others' recommended definitions for response, remission, recovery, relapse, and recurrence [74, 75]. Without consensus on these terms, confident interpretation of clinical outcomes is compromised. The ultimate goal of patient-oriented research is to effect change in community practice, provide clinicians and patients the knowledge necessary to inform treatment for MDD and make cost effective decisions, and most important to promote complete recovery [76].

In conclusion, based on the advances in ECT and evidence-based psychotherapies, their combined use warrants reappraisal and further investigation in the treatment and management of patients with MDD. As newer, more effective antidepressant strategies are needed and developed to prevent relapse and recurrence [77, 78], there is a vital interest in the development and evolution of multimodal therapies that are both individualized and targeted to the specific psychiatric disorders and targeted to unique patient groups [79]. Given the limited uncontrolled, yet encouraging prior findings [80], future research is warranted to better integrate the beneficial attributes of ECT and evidenced-based psychotherapy. Thus, we hypothesize that the proposed combined or augmented uses may benefit patients, and that this intervention strategy is worthy of rigorous testing employing cutting edge research methodologies.

Table 1
Studies that Examined the Combination of Electroconvulsive Therapy and Psychotherapy

Acknowledgments

This publication was supported by Grant Number KL2RR024983 (PI: Milton Packer) from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH), Grant Number K23MH085007 (PI: Anna Brandon) and Grant Number K24 MH-001571 (PI: Robin B. Jarrett) from the National Institute of Mental Health (NIMH), and Grant Number 05T-682 (PI: Mustafa M. Husain) from the Stanley Medical Research Institute. We appreciate the helpful recommendations of the reviewers for the Journal of ECT.

Footnotes

1The authors are using the conceptualization of response, remission, and recovery as defined by the American College of Neuropsychopharmacology Task Force (2006). Original articles included in this review use synonymous terms though with different meaning as they were published before publication of the ACNP Task Force. We present the terms as used in the original studies and when appropriate note the definition by either the ACNP Task force or the original study authors.

2Early studies reflect the terminology “electroshock therapy” and the abbreviation “EST.”

References

1. American Psychiatric Association Task Force on Electroconvulsive Therapy. The Practice of electroconvulsive therapy: Recommendations for treatment, training, and priileging. Washington, DC: American Psychiatric Association; 2001.
2. Fink M, Taylor MA. Electroconvulsive therapy: Evidence and challenges. Journal of the American Medical Association. 2007;298(3):330–332. [PubMed]
3. Daly JJ, et al. ECT in bipolar and unipolar depression: Differences in speed of response. Bipolar Disorders. 2001;3:95–104. [PubMed]
4. Husain MM, et al. Speed of response and remission in major depressive disorder with acute Electroconvulsive therapy (ECT): A consortium for research in ECT (CORE) report. Journal of Clinical Psychiatry. 2004;65(4):485–491. [PubMed]
5. Lisanby SH. Electroconvulsive Therapy for Depression. New England Journal of Medicine. 2007;357:1939–1945. [PubMed]
6. Sackeim HA, et al. Continuation Pharmacotherapy in the Prevention of Relapse Following Electroconvulsive Therapy: A Randomized Controlled Trial. JAMA. 2001;285(10):1299–1307. [PubMed]
7. Prudic JM, Sackeim HA, Rifas S. Medication resistance, response to ECT, and prevention of relapse. Psychiatric Annals. 1994;24(5):228–231.
8. Nobler MS, Sackeim HA. Augmentation strategies in electroconvulsive therapy: A synthesis. Convulsive Therapy. 1993;9(4):331–351. [PubMed]
9. Sackeim HA, et al. Effect of Concomitant Pharmacotherapy on Electroconvulsive Therapy Outcomes: Short-term Efficacy and Adverse Effects. Archives of General Psychiatry. 2009;66(7):729–737. [PubMed]
10. Kellner CH, et al. Continuation Electroconvulsive Therapy vs Pharmacotherapy for Relapse Prevention in Major Depression. Archives of General Psychiatry. 2006;63(12):1337–1344. [PubMed]
11. Lisanby SH, et al. Toward individualized post-electroconvulsive therapy care: Piloting the symptom-titrated, algorithm-based longitudinal (STABLE) intervention. Journal of ECT. 2008;24(3):179–182. [PMC free article] [PubMed]
12. Thase ME, et al. Cognitive Therapy Versus Medication in Augmentation and Switch Strategies as Second-Step Treatments: A STAR*D Report. American Journal of Psychiatry. 2007;164(5):739–752. [PubMed]
13. Beck AT, et al. Cognitive Therapy of Depression. New York, NY: The Guilford Press; 1979.
14. Klerman GL, Weissman MM. New applications of Interpersonal Psychotherapy. Washington, DC: American Psychiatric Press; 1993.
15. Klerman GL, et al. Interpersonal psychotherapy of depression. New York, NY: Basic Books; 1984.
16. Dunner DL, et al. Preventing recurrent Depression: Long-term treatment for major depressive disorder. Journal of Clinical Psychiatry. 2007;68(4):619–630. [PubMed]
17. Jarrett RB, Vittengl JR, Clark LA. How much cognitive therapy, for which patients, will prevent depressive relapse? Journal of Affective Disorders. 2008;111:185–192. [PMC free article] [PubMed]
18. Jarrett RB, et al. Preventing Recurrent Depression Using Cognitive Therapy With and Without a Continuation Phase: A Randomized Clinical Trial. Archives of General Psychiatry. 2001;58(4):381–388. [PMC free article] [PubMed]
19. Fava GA, et al. Six-Year Outcome of Cognitive Behavior Therapy for Prevention of Recurrent Depression. American Journal of Psychiatry. 2004;161(10):1872–1876. [PubMed]
20. Vittengl JR, Clark LA, Jarrett RB. Continuation-Phase Cognitive Therapy's Effects on Remission and Recovery From Depression. Journal of Consulting and Clinical Psychology. 2009;77(2):367–371. [PubMed]
21. Kashner TM, et al. Assessing the preventive effects of cognitive therapy following relief of depression: A methodological innovation. Journal of Affective Disorders. 2007;104(1-3):251–261. [PubMed]
22. Vittengl JR, et al. Reducing Relapse and Recurrence in Unipolar Depression: A Comparative Meta-Analysis of Cognitive-Behavioral Therapy's Effects. Journal of Consulting and Clinical Psychology. 2007;75(3):475–488. [PMC free article] [PubMed]
23. Schramm E, et al. Efficacy of interpersonal psychotherapy plus pharmacotherapy in chronically depressed inpatients. Journal of Affective Disorders. 2008;109(1-2):65–73. [PubMed]
24. Frank E, et al. Randomized trial of weekly, twice-monthly, and monthly interpersonal psychotherapy as maintenance treatment for women with recurrent depression. American Journal of Psychiatry. 2007;164(5):761–767. [PMC free article] [PubMed]
25. Hollon SD, et al. Psychotherapy and medication in the treatment of adult and geriatric depression: Which montherapy or combined treatment? Journal of Clinical Psychiatry. 2005;66(4):455–468. [PubMed]
26. DeRubeis RJ, et al. Cognitive Therapy vs Medications in the Treatment of Moderate to Severe Depression. Arch Gen Psychiatry. 2005;62(4):409–416. [PubMed]
27. Hollon SD, et al. Prevention of Relapse Following Cognitive Therapy vs Medications in Moderate to Severe Depression. Arch Gen Psychiatry. 2005;62(4):417–422. [PubMed]
28. Marcus ER, Bradley SS. Combination of psychotherapy and psychopharmacotherapy with treatment-resistant inpatients with dual diagnoses. Psychiatric Clinics of North America. 1990;13(2):209–214. [PubMed]
29. Arnow BA, Constantino MJ. Effectiveness of psychotherapy and combination treatment for chronic depression. Journal of Clinical Psychology. 2003;59(8):893–905. [PubMed]
30. Evans MD, et al. Differential Relapse Following Cognitive Therapy and Pharmacotherapy for Depression. Archives of General Psychiatry. 1992;49(10):802–808. [PubMed]
31. Nobler MS, et al. Decreased Regional Brain Metabolism After ECT. American Journal of Psychiatry. 2001;158(2):305–308. [PubMed]
32. Mayberg HS. Defining neurocircuits in depression: Strategies toward treatment selection based on neuroimaging phenotypes. Psychiatric Annals. 2006;36(4):259–268.
33. Beck AT. The evolution of the cognitive model of depression and its neurobiological correlates. American Journal of Psychiatry. 2008;165:969–977. [PubMed]
34. Goldapple K, et al. Modulation of Cortical-Limbic Pathways in Major Depression: Treatment-Specific Effects of Cognitive Behavior Therapy. Archives of General Psychiatry. 2004;61(1):34–41. [PubMed]
35. Brody AL, et al. Regional brain metabolic changes in patients with major depression treated with either paroxetine or interpersonal therapy: preliminary findings. Archives of General Psychiatry. 2001;58(7):631–40. see comment. [PubMed]
36. Sanacora G, et al. Cortical [gamma]-Aminobutyric Acid Concentrations in Depressed Patients Receiving Cognitive Behavioral Therapy. Biological Psychiatry. 2006;59(3):284–286. [PubMed]
37. Fenton L, et al. Can Cognitive Behavioral Therapy Reduce Relapse Rates of Depression After ECT? A Preliminary Study. Journal of ECT. 2006;22(3):196–198. [PubMed]
38. Sackeim HA, et al. The Cognitive Effects of Electroconvulsive Therapy in Community Settings. Neuropsychopharmacology. 2007;32(1):244–254. [PubMed]
39. Carey TS, Melvin CL, Ranney LM. Extracting key messages from systematic reviews. Journal of Psychiatric Practice. 2008;14(Suppl 1):28–34. [PubMed]
40. Milligan WL. Psychoneuroses treated with electrical convulsions. The Lancet. 1946;2:516–520. [PubMed]
41. Glueck BC, Reiss H, Bernard LE. Regressive Electric Shock Therapy. Psychiatric Quarterly. 1957;31:119–136. [PubMed]
42. Bonn EM, Boorstein S. Regressive electroshock therapy and anaclitic psychotherapy. Electroshock and Psychotherapy. Bulletin of the Menninger Clinic. 1959;23:190–201. [PubMed]
43. Jaffe J, et al. Modification of psychotherapeutic transactions by altered brain function. American Journal of Psychotherapy. 1961;15:46–55. [PubMed]
44. Cohen R. EST + Group Therapy = Improved Care. The American Journal of Nursing. 1971;71(6):1195–1198. [PubMed]
45. Thase ME, Friedman ES. Is psychotherapy an effective treatment for melancholia and other severe depressive states? Journal of Affective Disorders. 1999;54:1–19. [PubMed]
46. Yuuki N, et al. HPA axis normalization, estimated by DEX/CRH test, but less alteration on cerebral glucose metabolism in depressed patients receiving ECT after medication treatment failures. Acta Psychiatrica Scandinavica. 2005;112(4):257–265. [PubMed]
47. Hickie I, Parsonage B, Parker G. Prediction of response to electroconvulsive therapy. Preliminary validation of a sign-based typology. British Journal of Psychiatry. 1990;157:65–71. [PubMed]
48. Husain MM, et al. The efficacy of acute electroconvulsive therapy in atypical depression. Journal of Clinical Psychiatry. 2008;69:406–411. [PubMed]
49. Jarrett RB, et al. Treatment of Atypical Depression With Cognitive Therapy or Phenelzine: A Double-blind, Placebo-Controlled Trial. Archives of General Psychiatry. 1999;56(5):431–437. [PMC free article] [PubMed]
50. Petrides G, et al. ECT remission rates in psychotic versus nonpsychotic depressed patients: A report from CORE. Journal of ECT. 2001;17(4):244–253. [PubMed]
51. Jackson C, et al. Improving psychological adjustment following a first epidose of psychosis: A randomized controlled trial of cognitive therapy to reduce post psychotic trauma symptoms. Behaviour Research and Therapy. 2009;47(6):454–462. [PubMed]
52. Garety PA, et al. Cognitive-behavioural therapy and family intervention for relapse prevention and symptom reduction in psychosis: Randomized controlled trial. British Journal of Psychiatry. 2008;192(6):412–423. [PubMed]
53. Garety PA, et al. Cognitive behavioural therapy for drug-resistant psychosis. British Journal of Medical Psychology. 1994;67:259–271. [PubMed]
54. Conradi HJ, de Jonge P, Ormel J. Cognitive-behavioural therapy vs. usual care in recurrent depression. British Journal of Psychiatry. 2008;193(6):505–506. [PubMed]
55. Lynch D, Laws KR, McKenna PJ. Cognitive behavioural therapy for major psychiatric disorders: Does it really work? Psychological Medicine. 2009 epub ahead of print. [PubMed]
56. Watkins E, et al. Rumination-focused cognitive behaviour therapy for residual depression: A case series. Behaviour Research and Therapy. 2007;45(9):2144–2154. [PubMed]
57. Kellner CH, et al. Relief of Expressed Suicidal Intent by ECT: A Consortium for Research in ECT Study. American Journal of Psychiatry. 2005;162(5):977–982. [PubMed]
58. Stellrecht NE, et al. Clinical applications of the interpersonal-psychological theory of attempted and completed suicides. Journal of Clinial Psychology. 2006;62(2):211–222. [PubMed]
59. Coleman D, Casey JT. Therapeutic mechanisms of suicidal ideation: The influcence of changes in automatic thoughts and immature defenses. Crisis: The Journal of Intervention and Suicide Prevention. 2007;28(4):198–203. [PubMed]
60. Heisel MJ, et al. Adapating interpersonal psychotherapy for adults at risk for suicide: Preliminary findings. Professional Psychology: Research and Practice. 2009;40(2):156–164. [PMC free article] [PubMed]
61. Squire LR, Chace PM. Memory functions six to nine months after electroconvulsive therapy. Convulsive Therapy. 1996;12(4):240–256. [PubMed]
62. Fraser LM, O'Carroll RE, Ebmeier KP. The effect of electroconvulsive therapy on autobiographical memory: A systematic review. Journal of ECT. 2008;24(1):10–17. [PubMed]
63. Prudic J. Strategies to minimize cognitive side effects with ECT: Aspects of ECT technique. Journal of ECT. 2008;24(1):46–51. [PubMed]
64. Loo C, et al. A report on mood and cognitive outcomes with right unilateral ultrabrief pulsewidth (0.3 ms) ECT and retrospective comparison with standard pulsewidth right unilateral ECT. Journal of Affective Disorders. 2007;103(1-3):277–281. [PubMed]
65. Sackeim HA, et al. Effects of pulse width and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. Brain Stimulation. 2008;1(2):71–83. [PMC free article] [PubMed]
66. Sienaert P, et al. Randomized comparison of ultra-brief bifrontal and unilateral electroconvulsive therapy for major depression: cognitive side-effects. Journal of Affective Disorders. 2010;122(1-2):60–67. [PubMed]
67. Overholser JC. Cognitive-behavioral treatment of depression: A three-stage model to guide treatment planning. Cognitive and Behavioral Practice. 2003;10:231–239.
68. Dozois DJA, Dobson KS. A Longitudinal Investigation of Information Processing and Cognitive Organization in Clinical Depression: Stability of Schematic Interconnectedness. Journal of Consulting and Clinical Psychology. 2001;69(6):914–925. [PubMed]
69. Hollon SD, Stewart MO, Strunk D. Enduring effects for cognitive beahvior therapy in the treatment of depression and anxiety. Annual Review of Psychology. 2006;57:285–315. [PubMed]
70. Post F. Psychotherapy, electro-convulsive treatments, and longterm management of elderly depressives. Journal of Affective Disorders. 1985;8(Supplement 1):S41–S45. [PubMed]
71. Shelton RC. Long-term management of depression: Tips for adjusting the treatment plan as the patient's needs change. Journal of Clinical Psychiatry. 2009;70(Suppl 6):32–37. [PubMed]
72. Folstein MF, Folstein SE, Fanjiang G. MMSE: Mini-Mental State Examination Clinical Guide. Lutz, FL: Psychological Assessment Resources, Inc.; 2001.
73. Nasreddine ZS, et al. The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment. Journal of the American Geriatrics Society. 2005;53(4):695–699. [PubMed]
74. Rush AJ, et al. Report by the ACNP Task Force on response and remission in major depressive disorder. Neuropsychopharmacology. 2006;31:1841–1853. [PubMed]
75. Frank E, et al. Conceptualization and rationale for consensus definitions of terms in major depressive disorder: Response, remission, recovery, relapse, and recurrence. Archives of General Psychiatry. 1991;48:851–855. [PubMed]
76. Weiss AP, Guidi J, Fava M. Closing the efficacy-effectiveness gap: Translating both the what and the how from randomized controlled trials to clinical practice. Journal of Clinical Psychiatry. 2009;70(4):446–449. [PubMed]
77. Fava GA, Park SK, Sonino N. Treatment of recurrent depression. Expert Review of Neurotherapeutics. 2006;6(11):1735–1740. [PubMed]
78. Petersen TJ. Enhancing the efficacy of antidepressants wtih psychotherapy. Journal of Psychopharmacology. 2006;20(Supplement 3):19–28. [PubMed]
79. Insel TR. Translating Scientific Opportunity Into Public Health Impact: A Strategic Plan for Research on Mental Illness. Arch Gen Psychiatry. 2009;66(2):128–133. [PubMed]
80. Abse DW, Ewing JA. Transference and countertransference in somatic therapies. Journal of Nervous and Mental Disease. 1956;123(1):32–40. [PubMed]